Ito, S., Hidaka, Y., Inoue, N., Kaname, S., Kato, H., Matsumoto, M., . . . Kagami, S. (2018). Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: Interim analysis of post-marketing surveillance. Clin Exp Nephrol.
Chicago Style citaatIto, Shuichi, et al. "Safety and Effectiveness of Eculizumab for Pediatric Patients With Atypical Hemolytic–uremic Syndrome in Japan: Interim Analysis of Post-marketing Surveillance." Clin Exp Nephrol 2018.
MLA citatieIto, Shuichi, et al. "Safety and Effectiveness of Eculizumab for Pediatric Patients With Atypical Hemolytic–uremic Syndrome in Japan: Interim Analysis of Post-marketing Surveillance." Clin Exp Nephrol 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.